Delivery Order SPE2DB20D3505-SPE2DB24FU4M4
Award Date
6/14/24
Potential Completion Date
6/17/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,039.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of cyclosporine 0.05% eye emulsion, a specialty medication, to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,450.49, is for the delivery of Cyclosporine 0.05% Eye Emulsion 30s, a specialty pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC,...
This federal contract award, valued at $7,334.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% Eye Emulsion, a specialty pharmaceutical product, with an ultimate completion date of November 5, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, valued at $5,307.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty medication, to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty medication, with a ceiling value of $5,707.06 and a performance period through January 17, 2025. The contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,728.40 firm-fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion medication, with a completion date of June 30, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $18,302.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialized ophthalmic medication, to support military healthcare programs. The contract has an ultimate completion date of January 8, 2025 and is a Firm Fixed Price Delivery Order. This award is part of AmerisourceBergen's...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,527.92 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product. The contract has a completion date of November 1, 2024 and was awarded on October 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $2,506.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty medication, to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
This federal contract award, valued at $4,972.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of cyclosporine 0.05% eye emulsion in 30-count packages. The award is not associated with a set-aside program and represents an open competition. It is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...